Cargando…
Antibiotic-Free Selection in Biotherapeutics: Now and Forever
The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493468/ https://www.ncbi.nlm.nih.gov/pubmed/25854922 http://dx.doi.org/10.3390/pathogens4020157 |
_version_ | 1782379921435262976 |
---|---|
author | Mignon, Charlotte Sodoyer, Régis Werle, Bettina |
author_facet | Mignon, Charlotte Sodoyer, Régis Werle, Bettina |
author_sort | Mignon, Charlotte |
collection | PubMed |
description | The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world. |
format | Online Article Text |
id | pubmed-4493468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-44934682015-07-07 Antibiotic-Free Selection in Biotherapeutics: Now and Forever Mignon, Charlotte Sodoyer, Régis Werle, Bettina Pathogens Review The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world. MDPI 2015-04-03 /pmc/articles/PMC4493468/ /pubmed/25854922 http://dx.doi.org/10.3390/pathogens4020157 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mignon, Charlotte Sodoyer, Régis Werle, Bettina Antibiotic-Free Selection in Biotherapeutics: Now and Forever |
title | Antibiotic-Free Selection in Biotherapeutics: Now and Forever |
title_full | Antibiotic-Free Selection in Biotherapeutics: Now and Forever |
title_fullStr | Antibiotic-Free Selection in Biotherapeutics: Now and Forever |
title_full_unstemmed | Antibiotic-Free Selection in Biotherapeutics: Now and Forever |
title_short | Antibiotic-Free Selection in Biotherapeutics: Now and Forever |
title_sort | antibiotic-free selection in biotherapeutics: now and forever |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493468/ https://www.ncbi.nlm.nih.gov/pubmed/25854922 http://dx.doi.org/10.3390/pathogens4020157 |
work_keys_str_mv | AT mignoncharlotte antibioticfreeselectioninbiotherapeuticsnowandforever AT sodoyerregis antibioticfreeselectioninbiotherapeuticsnowandforever AT werlebettina antibioticfreeselectioninbiotherapeuticsnowandforever |